Health Effects Assessment Summary (HEAST) for
Toxaphene
CAS: 008001-35-2
| Summary of HEAST Information on-Line | ||||||||||||
| Carcinogenicity | ||||||||||||
|
| Inhalation [Slope Factor]: (see comment) | 1.1E+0 (mg/kg/day)-1 | |||
| Route: | Oral: diet | |||
| Target Organ / Cancer: | Liver / Tumors | |||
| Species | Experiment Length | EPA Group | ||
| Mouse | 18 months | IRIS | ||
| References | ||||
| 1978 | Litton Bionetics, Inc. 1978. Carcinogenic evaluation in mice: Toxaphene. Prepared by Litton Bionetics, Inc., Kensington, MD for Hercules, Inc, Wilmington, DE. LBI project No. 20602. | |||
| 1987 | U.S. EPA. 1987. Health effects assessment for Toxaphene. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Emergency and Remedial Response, Washington, DC. | |||
| 1980 | U.S. EPA. 1980. Ambient Water Quality Criteria document for Toxaphene. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Water Regulations and Standards, Washington, DC. | |||
| 1987 | U.S. EPA. 1987. Carcinogen Risk Assessment Verification Endeavor (CRAVE) Work Group. | |||
| Inhalation Slope Comment: | See Appendix A-II, Dose Conversions on HEAST. | |||
[ Risk Assessment Home ]
[ EPA Home |
OSWER Home | Superfund Home ]
[ Search EPA
| Search Superfund
| Whats New |
Contact Us ]
URL: http://risk.lsd.ornl.gov/epa/heast/heast_select.htm
This page was last updated on: March 1, 2000
Site maintained by: Office of Emergency and Remedial Response
Hofmann.Lee@epamail.epa.gov